Literature DB >> 27236197

Carbohydrates as T-cell antigens with implications in health and disease.

Lina Sun1, Dustin R Middleton1, Paeton L Wantuch1, Ahmet Ozdilek1, Fikri Y Avci2.   

Abstract

Glycosylation is arguably the most ubiquitous post-translational modification on proteins in microbial and mammalian cells. During the past few years, there has been intensive research demonstrating that carbohydrates, either in pure forms or in conjunction with proteins or lipids, evoke and modulate adaptive immune responses. We now know that carbohydrates can be directly recognized by T cells or participate in T-cell stimulation as components of T-cell epitopes. T-cell recognition of carbohydrate antigens takes place via their presentation by major histocompatibility complex pathways on antigen-presenting cells. In this review, we summarize studies on carbohydrates as T-cell antigens modulating adaptive immune responses. Through discussion of glycan-containing antigens, such as glycoproteins, glycolipids, zwitterionic polysaccharides and carbohydrate-based glycoconjugate vaccines, we will illustrate the key molecular and cellular interactions between carbohydrate antigens and T cells and the implications of these interactions in health and disease.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adaptive immunity; glycoconjugate; glycolipid; glycopeptide; glycoprotein

Mesh:

Substances:

Year:  2016        PMID: 27236197      PMCID: PMC6086537          DOI: 10.1093/glycob/cww062

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  139 in total

1.  Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Authors:  J S Haurum; I B Høier; G Arsequell; A Neisig; G Valencia; J Zeuthen; J Neefjes; T Elliott
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

Review 2.  Bacterial capsular antigens. Structural patterns of capsular antigens.

Authors:  Yu S Ovodov
Journal:  Biochemistry (Mosc)       Date:  2006-09       Impact factor: 2.487

3.  Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.

Authors:  A O Tzianabos; J Y Wang; J C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

4.  B cell mitogenic properties of thymus-independent antigens.

Authors:  A Coutinho; G Möller
Journal:  Nat New Biol       Date:  1973-09-05

5.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway.

Authors:  Jinyou Duan; Fikri Y Avci; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-01       Impact factor: 11.205

7.  Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.

Authors:  J S Haurum; L Tan; G Arsequell; P Frodsham; A C Lellouch; P A Moss; R A Dwek; A J McMichael; T Elliott
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

8.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.

Authors:  R M Chicz; W S Lane; R A Robinson; M Trucco; J L Strominger; J C Gorga
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

9.  The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Authors:  H Kitamura; K Iwakabe; T Yahata; S Nishimura; A Ohta; Y Ohmi; M Sato; K Takeda; K Okumura; L Van Kaer; T Kawano; M Taniguchi; T Nishimura
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.

Authors:  Manjunatha M Venkataswamy; Tony W Ng; Shalu S Kharkwal; Leandro J Carreño; Alison J Johnson; Shajo Kunnath-Velayudhan; Zheng Liu; Robert Bittman; Peter J Jervis; Liam R Cox; Gurdyal S Besra; Xiangshu Wen; Weiming Yuan; Moriya Tsuji; Xiangming Li; David D Ho; John Chan; Sunhee Lee; Richard Frothingham; Barton F Haynes; Michael W Panas; Geoffrey O Gillard; Jaimie D Sixsmith; Birgit Korioth-Schmitz; Joern E Schmitz; Michelle H Larsen; William R Jacobs; Steven A Porcelli
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

View more
  26 in total

1.  Improving vaccines against Streptococcus pneumoniae using synthetic glycans.

Authors:  Paulina Kaplonek; Naeem Khan; Katrin Reppe; Benjamin Schumann; Madhu Emmadi; Marilda P Lisboa; Fei-Fei Xu; Adam D J Calow; Sharavathi G Parameswarappa; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

2.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

Review 3.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

4.  Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.

Authors:  Lina Sun; Mayumi Ishihara; Dustin R Middleton; Michael Tiemeyer; Fikri Y Avci
Journal:  J Biol Chem       Date:  2018-08-16       Impact factor: 5.157

Review 5.  Glycosylation as a key parameter in the design of nucleic acid vaccines.

Authors:  Ahmet Ozdilek; Fikri Y Avci
Journal:  Curr Opin Struct Biol       Date:  2022-03-04       Impact factor: 6.809

6.  Glycan Microarrays Containing Synthetic Streptococcus pneumoniae CPS Fragments and Their Application to Vaccine Development.

Authors:  Paulina Kaplonek; Peter H Seeberger
Journal:  Methods Mol Biol       Date:  2022

7.  Invasive pneumococcal disease in relation to vaccine type serotypes.

Authors:  Paeton L Wantuch; Fikri Y Avci
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

Review 8.  Recent advances on smart glycoconjugate vaccines in infections and cancer.

Authors:  Marko Anderluh; Francesco Berti; Anna Bzducha-Wróbel; Fabrizio Chiodo; Cinzia Colombo; Federica Compostella; Katarzyna Durlik; Xhenti Ferhati; Rikard Holmdahl; Dragana Jovanovic; Wieslaw Kaca; Luigi Lay; Milena Marinovic-Cincovic; Marco Marradi; Musa Ozil; Laura Polito; Josè Juan Reina; Celso A Reis; Robert Sackstein; Alba Silipo; Urban Švajger; Ondřej Vaněk; Fumiichiro Yamamoto; Barbara Richichi; Sandra J van Vliet
Journal:  FEBS J       Date:  2021-06-01       Impact factor: 5.622

Review 9.  The Intestinal Commensal, Bacteroides fragilis, Modulates Host Responses to Viral Infection and Therapy: Lessons for Exploration during Mycobacterium tuberculosis Infection.

Authors:  Osagie A Eribo; Nelita du Plessis; Novel N Chegou
Journal:  Infect Immun       Date:  2021-10-04       Impact factor: 3.609

10.  T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of Streptococcus pneumoniae.

Authors:  Dustin R Middleton; Lina Sun; Amy V Paschall; Fikri Y Avci
Journal:  J Immunol       Date:  2017-05-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.